Cargando…
Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer
SIMPLE SUMMARY: Stromal tumor infiltrating lymphocytes (sTIL) are a validated predictive and prognostic biomarker in non-luminal breast cancer. Our aim was to evaluate their clinical relevance in luminal (hormone receptor positive, HER2 negative) early breast cancer. Our results show that, although...
Autores principales: | García-Torralba, Esmeralda, Pérez Ramos, Miguel, Ivars Rubio, Alejandra, Navarro-Manzano, Esther, Blaya Boluda, Noel, de la Morena Barrio, Pilar, García-Garre, Elisa, Martínez Díaz, Francisco, Chaves-Benito, Asunción, García-Martínez, Elena, Ayala de la Peña, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216816/ https://www.ncbi.nlm.nih.gov/pubmed/37345183 http://dx.doi.org/10.3390/cancers15102846 |
Ejemplares similares
-
A new prognostic model including immune biomarkers, genomic proliferation tumor markers (AURKA and MYBL2) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients
por: García-Torralba, Esmeralda, et al.
Publicado: (2023) -
Prognostic and Predictive Effects of Tumor and Plasma miR-200c-3p in Locally Advanced and Metastatic Breast Cancer
por: Navarro-Manzano, Esther, et al.
Publicado: (2022) -
Neutrophil-lymphocyte ratio in metastatic breast cancer is not an independent predictor of survival, but depends on other variables
por: Ivars Rubio, Alejandra, et al.
Publicado: (2019) -
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
por: Kos, Zuzana, et al.
Publicado: (2020) -
Angiogenic role of miR-20a in breast cancer
por: Luengo-Gil, Gines, et al.
Publicado: (2018)